BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25423552)

  • 1. Outcomes and Management Considerations in Patients on Dialysis Undergoing Laparoscopic Radical Nephrectomy for Renal-Cell Carcinoma.
    Keehn A; Maiman R; Agalliu I; Taylor J; Ghavamian R
    J Endourol; 2015 Jun; 29(6):691-5. PubMed ID: 25423552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transperitoneal laparoscopic radical nephrectomy for patients with dialysis-dependent end-stage renal disease: an analysis and comparison of perioperative outcome.
    Bird VG; Shields JM; Aziz M; De Los Santos R; Ayyathurai R; Ciancio G
    Urology; 2010 Jun; 75(6):1335-42. PubMed ID: 20035985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.
    Schmitges J; Trinh QD; Sun M; Hansen J; Bianchi M; Jeldres C; Perrotte P; Dahlem R; Shariat SF; Chun FK; Montorsi F; Menon M; Fisch M; Graefen M; Karakiewicz PI
    BJU Int; 2012 Sep; 110(6 Pt B):E183-90. PubMed ID: 22321256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease.
    Takagi T; Kondo T; Omae K; Iizuka J; Kobayashi H; Yoshida K; Hashimoto Y; Tanabe K
    Int Urol Nephrol; 2016 Sep; 48(9):1421-7. PubMed ID: 27193433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative outcomes of laparoscopic radical nephrectomy for renal cell carcinoma in patients with dialysis-dependent end-stage renal disease.
    Yamashita K; Ito F; Nakazawa H
    Ther Apher Dial; 2012 Jun; 16(3):254-9. PubMed ID: 22607569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population.
    Breda A; Lucarelli G; Rodriguez-Faba O; Guirado L; Facundo C; Bettocchi C; Gesualdo L; Castellano G; Grandaliano G; Battaglia M; Palou J; Ditonno P; Villavicencio H
    World J Urol; 2015 Jan; 33(1):1-7. PubMed ID: 24504760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-center comparison of purely laparoscopic, hand-assisted laparoscopic, and open radical nephrectomy in patients at high anesthetic risk.
    Baldwin DD; Dunbar JA; Parekh DJ; Wells N; Shuford MD; Cookson MS; Smith JA; Herrell SD; Chang SS; McDougall EM
    J Endourol; 2003 Apr; 17(3):161-7. PubMed ID: 12803988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis.
    Nouh MA; Kuroda N; Yamashita M; Hayashida Y; Yano T; Minakuchi J; Taniguchi S; Nomura I; Inui M; Sugimoto M; Kakehi Y
    BJU Int; 2010 Mar; 105(5):620-7. PubMed ID: 19747356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal cell carcinoma outcomes in end-stage renal disease: A 40-year study from two Japanese institutions.
    Ishihara H; Ikeda T; Fukuda H; Yoshida K; Kobayashi H; Iizuka J; Nagashima Y; Kondo T; Takagi T
    Int J Urol; 2024 Jan; 31(1):73-81. PubMed ID: 37798866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.
    Neuzillet Y; Tillou X; Mathieu R; Long JA; Gigante M; Paparel P; Poissonnier L; Baumert H; Escudier B; Lang H; Rioux-Leclercq N; Bigot P; Bernhard JC; Albiges L; Bastien L; Petit J; Saint F; Bruyere F; Boutin JM; Brichart N; Karam G; Branchereau J; Ferriere JM; Wallerand H; Barbet S; Elkentaoui H; Hubert J; Feuillu B; Theveniaud PE; Villers A; Zini L; Descazeaux A; Roupret M; Barrou B; Fehri K; Lebret T; Tostain J; Terrier JE; Terrier N; Martin L; Dugardin F; Galliot I; Staerman F; Azemar MD; Irani J; Tisserand B; Timsit MO; Sallusto F; Rischmann P; Guy L; Valeri A; Deruelle C; Azzouzi AR; Chautard D; Mejean A; Salomon L; Rigaud J; Pfister C; SouliƩ M; Kleinclauss F; Badet L; Patard JJ; ;
    Eur Urol; 2011 Aug; 60(2):366-73. PubMed ID: 21377780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of American Society of Anesthesiologists physical status classification to assess perioperative risk in patients undergoing radical nephrectomy for renal cell carcinoma.
    Han KR; Kim HL; Pantuck AJ; Dorey FJ; Figlin RA; Belldegrun AS
    Urology; 2004 May; 63(5):841-6; discussion 846-7. PubMed ID: 15134960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroperitoneal Laparoscopic Radical Nephrectomy Allows Continuation of Peritoneal Dialysis in Patients with End-Stage Renal Disease.
    Khambati A; Fitzgerald MK; Perry KT; Nadler RB
    Perit Dial Int; 2017; 37(3):340-342. PubMed ID: 28512163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Postoperative Complications in Patients Who Undergo Radical Nephrectomy and IVC Thrombectomy: A Large Contemporary Tertiary Center Analysis.
    Lue K; Russell CM; Fisher J; Kurian T; Agarwal G; Luchey A; Poch M; Pow-Sang JM; Sexton WJ; Spiess PE
    Clin Genitourin Cancer; 2016 Feb; 14(1):89-95. PubMed ID: 26453395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicted versus observed 30-day perioperative outcomes using the ACS NSQIP surgical risk calculator in patients undergoing partial nephrectomy for renal cell carcinoma.
    Blair BM; Lehman EB; Jafri SM; Kaag MG; Raman JD
    Int Urol Nephrol; 2018 Jul; 50(7):1249-1256. PubMed ID: 29868938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma in dialysis patients: a single center experience.
    Kojima Y; Takahara S; Miyake O; Nonomura N; Morimoto A; Mori H
    Int J Urol; 2006 Aug; 13(8):1045-8. PubMed ID: 16903927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of comorbidity on complications after nephrectomy: use of the Clavien Classification of Surgical Complications.
    Hennus PM; Kroeze SG; Bosch JL; Jans JJ
    BJU Int; 2012 Sep; 110(5):682-7. PubMed ID: 22432906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial nephrectomy for the treatment of renal cell carcinoma (RCC) and the risk of end-stage renal disease (ESRD).
    Yap SA; Finelli A; Urbach DR; Tomlinson GA; Alibhai SM
    BJU Int; 2015 Jun; 115(6):897-906. PubMed ID: 25065448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal cell carcinoma as a cause of end-stage renal disease in the United States: patient characteristics and survival.
    Stiles KP; Moffatt MJ; Agodoa LY; Swanson SJ; Abbott KC
    Kidney Int; 2003 Jul; 64(1):247-53. PubMed ID: 12787416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Perioperative Death Following Surgery for Renal Cell Carcinoma with Vein Involvement: A Retrospective Study.
    Akkoyun M; Merseburger AS; Kramer MW; Herrmann TR; Kuczyk MA; von Klot CA
    Adv Ther; 2015 Aug; 32(8):783-97. PubMed ID: 26350620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
    Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
    BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.